David Greenwald
Direttore/Membro del Consiglio presso Jaguar Gene Therapy LLC
Posizioni attive di David Greenwald
Società | Posizione | Inizio | Fine |
---|---|---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investitore di Private Equity | 01/09/2018 | - |
Innervace, Inc.
Innervace, Inc. BiotechnologyHealth Technology Innervace, Inc. is an American regenerative therapy company that develops technology to replace lost connections due to brain degeneration or injury. The company is based in Philadelphia, PA. The company's lead program focuses on mimicking the lost nigrostriatal pathway in patients with Parkinson's disease. The company was founded by Kacy Cullen and Douglas Smith, and the CEO is Nader Halim. | Direttore/Membro del Consiglio | 01/08/2022 | - |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Direttore/Membro del Consiglio | 01/02/2020 | - |
Storia della carriera di David Greenwald
Precedenti posizioni note di David Greenwald
Società | Posizione | Inizio | Fine |
---|---|---|---|
Johns Hopkins Technology Ventures | Direttore/Membro del Consiglio | 01/06/2014 | 01/09/2018 |
Decision Resources, Inc.
Decision Resources, Inc. Investment ManagersFinance Decision Resources, Inc. provides information, analysis, and insight on critical issues to the healthcare industry worldwide. It provides market research publications, advisory and consulting services for pharmaceutical companies, managed care organizations, and medical device manufacturers. The company was founded in 1990 and is headquartered in Burlington, MA. | Direttore/Membro del Consiglio | 01/01/2014 | 01/07/2015 |
Relay Technology Management, Inc.
Relay Technology Management, Inc. Miscellaneous Commercial ServicesCommercial Services Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development. Data-driven decision-making in turn will lead to cures for patients around the world becoming available faster. The Relay Innovation Engine software platform powers the Business Development Live software-as-a-service and their strategy consulting practice, which supports business development and corporate strategy professionals by aggregating scientific, business and medical data in an actionable context. Relay works with life science companies to increase the efficiency of drug development by offering a transparent, objective and scalable approach to business intelligence and analytics. Relay was founded by David Greenwald, Ph.D. and Brigham Hyde, Ph.D. | Amministratore Delegato | 01/06/2007 | 01/01/2014 |
Fondatore | 01/06/2007 | 01/01/2014 |
Formazione di David Greenwald
Tufts University School of Medicine | Doctorate Degree |
University of Maryland | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Cina | 2 |
Posizioni
Director/Board Member | 4 |
Private Equity Investor | 1 |
Chief Executive Officer | 1 |
Settori
Finance | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 6 |
---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Finance |
Johns Hopkins Technology Ventures | |
Relay Technology Management, Inc.
Relay Technology Management, Inc. Miscellaneous Commercial ServicesCommercial Services Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development. Data-driven decision-making in turn will lead to cures for patients around the world becoming available faster. The Relay Innovation Engine software platform powers the Business Development Live software-as-a-service and their strategy consulting practice, which supports business development and corporate strategy professionals by aggregating scientific, business and medical data in an actionable context. Relay works with life science companies to increase the efficiency of drug development by offering a transparent, objective and scalable approach to business intelligence and analytics. Relay was founded by David Greenwald, Ph.D. and Brigham Hyde, Ph.D. | Commercial Services |
Decision Resources, Inc.
Decision Resources, Inc. Investment ManagersFinance Decision Resources, Inc. provides information, analysis, and insight on critical issues to the healthcare industry worldwide. It provides market research publications, advisory and consulting services for pharmaceutical companies, managed care organizations, and medical device manufacturers. The company was founded in 1990 and is headquartered in Burlington, MA. | Finance |
Innervace, Inc.
Innervace, Inc. BiotechnologyHealth Technology Innervace, Inc. is an American regenerative therapy company that develops technology to replace lost connections due to brain degeneration or injury. The company is based in Philadelphia, PA. The company's lead program focuses on mimicking the lost nigrostriatal pathway in patients with Parkinson's disease. The company was founded by Kacy Cullen and Douglas Smith, and the CEO is Nader Halim. | Health Technology |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Health Services |
- Borsa valori
- Insiders
- David Greenwald
- Esperienza